# Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints

> **NCT03166410** · NA · UNKNOWN · sponsor: **Texas Plastic Surgery** · enrollment: 500 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **PROCEDURE:** Cell injection

## Key facts

- **NCT ID:** NCT03166410
- **Lead sponsor:** Texas Plastic Surgery
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166410, "Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03166410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*